Toxicity of platinum compounds

Jörg T. Hartmann(University of Tübingen), Hans‐Peter Lipp(University of Zurich)

Expert Opinion on Pharmacotherapy

June 1, 2003

10.1517/14656566.4.6.889

Cited by 576

Related Papers

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

|The Lancet|2019|2.6k

Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein

|Nature|1992|1.6k

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

|The Lancet Oncology|2014|1.2k

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

|The Lancet Oncology|2009|960

Arc/Arg3.1 Is Essential for the Consolidation of Synaptic Plasticity and Memories

|Neuron|2006|836